Outlook Therapeutics (OTLK) Cash from Investing Activities (QoQ) (2015 - 2019)
Outlook Therapeutics (OTLK) Cash from Investing Activities (QoQ) (2015 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 100.00% |
| Jun 30, 2019 | -200.66% |
| Mar 31, 2019 | 78.79% |
| Dec 31, 2018 | 81.28% |
| Sep 30, 2018 | -651.56% |
| Jun 30, 2018 | 38.94% |
| Mar 31, 2018 | 74.40% |
| Dec 31, 2017 | -4,383.50% |
| Sep 30, 2017 | 68.54% |
| Jun 30, 2017 | -75.18% |
| Mar 31, 2017 | 70.67% |
| Dec 31, 2016 | 54.82% |
| Sep 30, 2016 | 27.42% |
| Jun 30, 2016 | -1,063.76% |
| Mar 31, 2016 | 112.89% |
| Dec 31, 2015 | 88.94% |
| Sep 30, 2015 | 5.58% |